Xeloda Clinical Trials
2 recruitingDrug
Phase 41Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Metastatic Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute15 enrolled1 locationNCT06409390
Recruiting
Phase 4
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Breast NeoplasmsColorectal NeoplasmsHead and Neck Neoplasms+1 more
Rutgers, The State University of New Jersey100 enrolled12 locationsNCT07158164